Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889570) titled 'A Controlled Study to Evaluate the Effects of a Supplement on Weight Loss, Blood Sugar, and Appetite Suppression' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Evolv
Condition:
Overweight
Obesity
Blood Sugar Regulation
Appetite Suppression
Weight Management
Intervention:
Dietary Supplement: Evolv GLP-1 Group
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: April 1, 2026
Target Sample Size: 98
Countries ...